Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen)

Julkaisu

Reference

Dennehy PH, Vesikari T, Matson DO, Et AL. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Hum Vaccines 2011:7(5):563-568.

Julkaisutiedot

Julkaisutyyppi: Alkuperäisartikkeli.
Kansainvälinen.
Kieli: Englanti.

Teksti/tiivistelmä: https://www.ncbi.nlm.nih.gov/pubmed/21441783

Publication data

Publication type: Original scientific article.
International.
In English.

Text/summary: https://www.ncbi.nlm.nih.gov/pubmed/21441783

Tekijät

Contributors

Tampereen yliopisto

Lääketieteen laitos/virologia 1
- Timo Vesikari

University of Tampere

Medical School/Department of Virology 1
- Timo Vesikari

Tampereen yliopistollinen sairaala

Lastentautien vastuualue
- Timo Vesikari

Tampere University Hospital

Julkaisutietokanta 31.1.2012

Publications Data Base 31.1.2012